• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灵长类动物模型中凝血因子V的周转率

Factor V turnover in a primate model.

作者信息

Rand M D, Hanson S R, Mann K G

机构信息

Department of Biochemistry, University of Vermont, College of Medicine, Burlington 05405-0068, USA.

出版信息

Blood. 1995 Oct 1;86(7):2616-23.

PMID:7670105
Abstract

The isolation and characterization of baboon plasma factor V (FV) were performed for the development of an in vivo model for studying factor V/Va physiology in nonhuman primates. Baboon FV was purified by immunoaffinity chromatography with an antihuman FV monoclonal antibody and exhibits a specific activity of 1,940 U/mg. Baboon FV activation by thrombin proceeds through two proteolytic pathways similar to those observed with human and bovine FV. Limited amino acid sequencing of FV and its thrombin activation fragments shows 95% identity with human and 79% identity with bovine FV. 125I-Factor V and a mixture of thrombin cleaved 125I-FV activation products were infused into normal male baboons and evaluated by blood sample radioactivity measurements and by autoradiography of plasma samples following resolution by gel electrophoresis. Factor V disappeared with a half-life (t1/2) of 12.98 +/- 1.85 hours and was cleared without obvious degradation of the molecule during circulation. The radioactivity associated with the thrombin activated FV mixture, which consisted of the Mr = 220,000 activation intermediate, the Mr = 150,000 activation peptide, the heavy chain (HC) and the light chain (LC) of FVa, was cleared in a nonlinear manner. The HC and LC were removed with t1/2 < 20 minutes. The apparent molecular weight (Mr) = 220,000 and Mr = 150,000 fragments were cleared with t1/2 > 6 hours and t1/2 > 30 hours, respectively.

摘要

为了建立一个研究非人灵长类动物中因子V/Va生理学的体内模型,对狒狒血浆因子V(FV)进行了分离和特性鉴定。用抗人FV单克隆抗体通过免疫亲和色谱法纯化狒狒FV,其比活性为1940 U/mg。凝血酶对狒狒FV的激活通过两条蛋白水解途径进行,这与在人和牛FV中观察到的途径相似。对FV及其凝血酶激活片段进行的有限氨基酸测序显示,与人类FV的同一性为95%,与牛FV的同一性为79%。将125I-因子V和凝血酶裂解的125I-FV激活产物混合物注入正常雄性狒狒体内,并通过血样放射性测量和凝胶电泳分离后血浆样品的放射自显影进行评估。因子V以12.98±1.85小时的半衰期(t1/2)消失,并且在循环过程中分子没有明显降解就被清除。与凝血酶激活的FV混合物相关的放射性以非线性方式清除,该混合物由Mr = 220,000的激活中间体、Mr = 150,000的激活肽、FVa的重链(HC)和轻链(LC)组成。HC和LC以t1/2 < 20分钟的速度被清除。表观分子量(Mr)= 220,000和Mr = 150,000的片段分别以t1/2 > 6小时和t1/2 > 30小时的速度被清除。

相似文献

1
Factor V turnover in a primate model.灵长类动物模型中凝血因子V的周转率
Blood. 1995 Oct 1;86(7):2616-23.
2
Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.辅因子凝血因子V上的碳水化合物部分而非衍生的辅因子凝血因子Va,调节其被活化蛋白C的失活。
Biochemistry. 2002 Feb 5;41(5):1672-80. doi: 10.1021/bi011304g.
3
Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.多聚蛋白1以高亲和力结合因子V和活化的因子V,并抑制凝血酶生成。
Thromb Haemost. 2008 Dec;100(6):1058-67.
4
Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.凝血因子V独特的体内修饰产生了一种在物理和功能上都截然不同的血小板衍生辅因子:纯化的血小板衍生因子V/Va的特性
J Biol Chem. 2004 Jan 23;279(4):2383-93. doi: 10.1074/jbc.M308600200. Epub 2003 Oct 31.
5
Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.巨核细胞内吞血浆来源的因子 V 后对其进行蛋白水解,形成血小板来源的因子 V/Va 池。
J Thromb Haemost. 2013 Aug;11(8):1532-9. doi: 10.1111/jth.12307.
6
Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.凝血因子V中各个活化蛋白C切割位点区域在因子Va失活和因子Xa激活中的重要性。
Eur J Biochem. 1999 Feb;260(1):64-75. doi: 10.1046/j.1432-1327.1999.00137.x.
7
Functional properties of recombinant factor V mutated in a potential calcium-binding site.在潜在钙结合位点发生突变的重组因子V的功能特性
Biochemistry. 2004 May 18;43(19):5803-10. doi: 10.1021/bi0361362.
8
Secretable human platelet-derived factor V originates from the plasma pool.可分泌的人血小板衍生因子V源自血浆池。
Blood. 1998 Nov 1;92(9):3035-41.
9
Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation.凝血因子V的C2结构域包含一个主要的凝血酶结合位点,该位点负责凝血酶催化的凝血因子V激活。
J Thromb Haemost. 2006 Jun;4(6):1354-60. doi: 10.1111/j.1538-7836.2006.01957.x.
10
Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.活化蛋白C抵抗的分子机制。从因子V基因中存在精氨酸506突变为谷氨酰胺纯合子的个体中分离出的因子V的特性。
Biochem J. 1996 Jan 15;313 ( Pt 2)(Pt 2):467-72. doi: 10.1042/bj3130467.

引用本文的文献

1
Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding.(超级)因子Va的安全性、稳定性及药代动力学特性,一种用于治疗严重出血的新型工程凝血因子V
Pharm Res. 2016 Jun;33(6):1517-26. doi: 10.1007/s11095-016-1895-3. Epub 2016 Mar 9.
2
Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.血小板和血小板衍生的因子Va在完全缺乏因子V的情况下赋予止血能力。
Blood. 2015 Jun 4;125(23):3647-50. doi: 10.1182/blood-2014-07-589580. Epub 2015 Apr 20.
3
A bipartite autoinhibitory region within the B-domain suppresses function in factor V.
因子 V 中 B 结构域内的二联体自身抑制区抑制其功能。
J Biol Chem. 2012 Jul 27;287(31):26342-51. doi: 10.1074/jbc.M112.377168. Epub 2012 Jun 15.